An IGF-Trap for cancer therapy

The Brodt laboratory engineered and developed a novel IGF-targeting molecule (the IGF-Trap) with otent anti-cancer effects. The objective of this project is to optimize the use of this potential drug in re-clinical cancer models and develop sensitive biomarkers for assessing and predicting its effect. In addition, the effect of this inhibitor on pancreatic cancer growth and metastasis and its utility in nononcology ndication will be evaluated. Ultimately, the expectation is to identify and engage a pharmaceutical partner for transition of this inhibitor to the clinic for cancer treatment.

Intern: 
Roni Rayes, Zarina D’Costa, Maria Celia Fernandez & TBD
Superviseur universitaire: 
Pnina Brodt
Project Year: 
2014
Province: 
Quebec
Université: 
Partenaire: 
Discipline: 
Programme: